"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,AU,B2,AU 2004/289544 B2,047-727-439-876-045,2011-03-31,2011,AU 2004/289544 A,2004-09-08,IN 946MU2003 A;;IN 2004000277 W,2003-09-11,A multi-layered tile or block,,GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/047-727-439-876-045,Granted Patent,no,3,0,6,6,0,B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B28/02;;C04B2111/00612;;C04B35/634;;C04B35/636;;C04B2237/32;;C04B2237/34;;C04B2237/341;;C04B2237/343;;C04B2237/365;;B32B2419/00;;B32B9/005;;B32B2305/30;;B32B13/02;;C04B28/00;;B32B18/00;;C04B26/00;;C04B2111/00612;;C04B28/02;;C04B35/634;;C04B2237/365;;C04B2237/34;;C04B2237/343;;C04B2237/32;;C04B2237/341;;C04B35/636,C04B28/02;;B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B41/50,,0,0,,,,INACTIVE
2,WO,A3,WO 2005/046984 A3,051-181-755-076-798,2005-08-18,2005,IN 2004000277 W,2004-09-08,IN 946MU2003 A,2003-09-11,A MULTI-LAYERED TILE OR BLOCK,"The present invention relates to a multi-layered tile or block comprising of at least three different layers wherein at least one layer comprises of a cementitious material, mixed with a filler and/or an aggregate.",GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/051-181-755-076-798,Search Report,yes,1,0,6,6,0,B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B28/02;;C04B2111/00612;;C04B35/634;;C04B35/636;;C04B2237/32;;C04B2237/34;;C04B2237/341;;C04B2237/343;;C04B2237/365;;B32B2419/00;;B32B9/005;;B32B2305/30;;B32B13/02;;C04B28/00;;B32B18/00;;C04B26/00;;C04B2111/00612;;C04B28/02;;C04B35/634;;C04B2237/365;;C04B2237/34;;C04B2237/343;;C04B2237/32;;C04B2237/341;;C04B35/636,B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B28/02;;C04B41/50,,1,0,,,"ASAOKA ET AL: ""Multi-layer composite ceramics and their manufacture"", CHEMICAL ABSTRACTS + INDEXES, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, 21 September 1992 (1992-09-21), XP000373653, ISSN: 0009-2258",PENDING
3,US,A1,US 2011/0178209 A1,117-079-718-168-521,2011-07-21,2011,US 200913119550 A,2009-09-18,IN 2013MU2008 A;;IN 2009000514 W,2008-09-19,MANUFACTURING HYDRAULIC CEMENT AGGREGATES FOR USE IN INSULATING AND HEAT REFLECTING PRODUCTS,"Insulation and heat resistance hydraulic cement aggregates comprising of white Portland cement, with or without additives and filler, magnesium oxide, zirconium compounds, marble, dolomite, granite, sand, talc, clays calcined, boron compounds, silicates, trap rock aggregate, polymeric binder/s optionally water.",GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/117-079-718-168-521,Patent Application,yes,7,5,9,9,0,C04B18/021;;C04B28/02;;C04B28/04;;C04B28/04;;C04B28/02;;C04B18/021,C04B24/26,524/5;;524/2;;524/8,0,0,,,,DISCONTINUED
4,AU,A1,AU 2004/289544 A1,012-148-781-321-76X,2005-05-26,2005,AU 2004/289544 A,2004-09-08,IN 946MU2003 A;;IN 2004000277 W,2003-09-11,A multi-layered tile or block,,ASHOK GANPULE,GANPULE ASHOK ANANT,,https://lens.org/012-148-781-321-76X,Patent Application,no,0,0,6,6,0,B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B28/02;;C04B2111/00612;;C04B35/634;;C04B35/636;;C04B2237/32;;C04B2237/34;;C04B2237/341;;C04B2237/343;;C04B2237/365;;B32B2419/00;;B32B9/005;;B32B2305/30;;B32B13/02;;C04B28/00;;B32B18/00;;C04B26/00;;C04B2111/00612;;C04B28/02;;C04B35/634;;C04B2237/365;;C04B2237/34;;C04B2237/343;;C04B2237/32;;C04B2237/341;;C04B35/636,C04B28/02;;B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B41/50,,0,0,,,,INACTIVE
5,AU,A1,AU 2009/305900 A1,044-215-276-824-700,2010-04-29,2010,AU 2009/305900 A,2009-09-18,IN 2013MU2008 A;;IN 2009000514 W,2008-09-19,Manufacturing hydraulic cement aggregates for use in insulating and heat reflecting products,,GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/044-215-276-824-700,Patent Application,no,0,0,9,9,0,C04B18/021;;C04B28/02;;C04B28/04;;C04B28/04;;C04B28/02;;C04B18/021,C04B7/02;;C04B14/04;;C04B16/04,,0,0,,,,DISCONTINUED
6,MY,A,MY 151324 A,116-419-860-067-133,2014-05-15,2014,MY PI20111049 A,2009-09-18,IN 2013MU2008 A,2008-09-19,MANUFACTURING HYDRAULIC CEMENT AGGREGATES FOR USE IN INSULATING AND HEAT REFLECTING PRODUCTS,"INSULATION AND HEAT RESISTANCE HYDRAULIC CEMENT AGGREGATES COMPRISING OF WHITE PORTLAND CEMENT, WITH OR WITHOUT ADDITIVES AND FILLER, MAGNESIUM OXIDE, ZIRCONIUM COMPOUNDS, MARBLE, DOLOMITE, GRANITE, SAND, TALC, CLAYS CALCINED, BORON COMPOUNDS, SILICATES, TRAP ROCK AGGREGATE, POLYMERIC BINDER/S OPTIONALLY WATER.",GANPULE AMIT ASHOK,ANANT GANPULE ASHOK,,https://lens.org/116-419-860-067-133,Granted Patent,no,0,0,9,9,0,C04B18/021;;C04B28/02;;C04B28/04;;C04B28/04;;C04B28/02;;C04B18/021,C04B7/02,,0,0,,,,ACTIVE
7,WO,A3,WO 2010/046909 A3,098-772-936-026-837,2012-06-21,2012,IN 2009000514 W,2009-09-18,IN 2013MU2008 A,2008-09-19,MANUFACTURING HYDRAULIC CEMENT AGGREGATES FOR USE IN INSULATING AND HEAT REFLECTING PRODUCTS,"Insulation and heat resistance hydraulic cement aggregates comprising of white Portland cement, with or without additives and filler, magnesium oxide, zirconium compounds, marble, dolomite, granite, sand, talc, clays calcined, boron compounds, silicates, trap rock aggregate, polymeric binder/s optionally water.",GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/098-772-936-026-837,Search Report,yes,3,0,9,9,0,C04B18/021;;C04B28/02;;C04B28/04;;C04B28/04;;C04B28/02;;C04B18/021,C04B18/02;;C04B28/02;;C04B28/04,,0,0,,,,PENDING
8,WO,A2,WO 2005/046984 A2,149-947-320-141-239,2005-05-26,2005,IN 2004000277 W,2004-09-08,IN 946MU2003 A,2003-09-11,A MULTI-LAYERED TILE OR BLOCK,"The present invention relates to a multi-layered tile or block comprising of at least three different layers wherein at least one layer comprises of a cementitious material, mixed with a filler and/or an aggregate.",GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/149-947-320-141-239,Patent Application,yes,0,0,6,6,0,B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B28/02;;C04B2111/00612;;C04B35/634;;C04B35/636;;C04B2237/32;;C04B2237/34;;C04B2237/341;;C04B2237/343;;C04B2237/365;;B32B2419/00;;B32B9/005;;B32B2305/30;;B32B13/02;;C04B28/00;;B32B18/00;;C04B26/00;;C04B2111/00612;;C04B28/02;;C04B35/634;;C04B2237/365;;C04B2237/34;;C04B2237/343;;C04B2237/32;;C04B2237/341;;C04B35/636,B32B13/02;;B32B18/00;;C04B26/00;;C04B28/00;;C04B28/02;;C04B41/50,,0,0,,,,PENDING
9,EP,A2,EP 2346794 A2,145-693-969-168-257,2011-07-27,2011,EP 09821689 A,2009-09-18,IN 2009000514 W;;IN 2013MU2008 A,2008-09-19,MANUFACTURING HYDRAULIC CEMENT AGGREGATES FOR USE IN INSULATING AND HEAT REFLECTING PRODUCTS,,GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/145-693-969-168-257,Patent Application,yes,0,0,9,9,0,C04B18/021;;C04B28/02;;C04B28/04;;C04B28/04;;C04B28/02;;C04B18/021,C04B7/02;;C04B14/04;;C04B16/04,,0,0,,,,DISCONTINUED
10,WO,A2,WO 2010/046909 A2,192-806-686-139-643,2010-04-29,2010,IN 2009000514 W,2009-09-18,IN 2013MU2008 A,2008-09-19,MANUFACTURING HYDRAULIC CEMENT AGGREGATES FOR USE IN INSULATING AND HEAT REFLECTING PRODUCTS,"Insulation and heat resistance hydraulic cement aggregates comprising of white Portland cement, with or without additives and filler, magnesium oxide, zirconium compounds, marble, dolomite, granite, sand, talc, clays calcined, boron compounds, silicates, trap rock aggregate, polymeric binder/s optionally water.",GANPULE ASHOK ANANT,GANPULE ASHOK ANANT,,https://lens.org/192-806-686-139-643,Patent Application,yes,0,4,9,9,0,C04B18/021;;C04B28/02;;C04B28/04;;C04B28/04;;C04B28/02;;C04B18/021,C04B7/02;;C04B14/04;;C04B16/04,,0,0,,,,PENDING
11,EP,A2,EP 2120886 A2,189-840-142-027-935,2009-11-25,2009,EP 07859517 A,2007-12-21,IB 2007055299 W;;IN 2751DE2006 A,2006-12-21,MODIFIED-RELEASE FORMULATIONS OF AZABICYCLO DERIVATIVES,,RANBAXY LAB LTD,KETKAR ANANT RAMESH;;KUMAR PRATIK;;RAMPAL ASHOK,,https://lens.org/189-840-142-027-935,Patent Application,yes,0,0,4,4,0,A61K31/403;;A61K31/403;;A61K9/0004;;A61K9/0004;;A61K9/2027;;A61K9/2027;;A61K9/2054;;A61K9/2054;;A61P1/00;;A61P11/00;;A61P13/00,A61K9/20;;A61K9/00;;A61K31/403,,1,0,,,See references of WO 2008075321A3,DISCONTINUED
12,US,A1,US 2008/0220064 A1,135-810-181-160-521,2008-09-11,2008,US 95188507 A,2007-12-06,IN 2615DE2006 A,2006-12-06,EXTENDED RELEASE MATRIX FORMULATIONS OF MORPHINE,"The present invention provides extended-release matrix formulations comprising a therapeutically effective amount of morphine or salt thereof, one or more hydrophilic controlled release polymers and one or more pharmaceutically acceptable excipients. The formulations provide extended release of morphine or salt thereof over a specified period of time after oral administration in humans or animals.",RAMESH KETKAR ANANT;;KUMAR PRATIK;;RAMPAL ASHOK,RAMESH KETKAR ANANT;;KUMAR PRATIK;;RAMPAL ASHOK,RANBAXY LABORATORIES LIMITED (2008-02-28),https://lens.org/135-810-181-160-521,Patent Application,yes,13,3,1,1,0,A61K9/2018;;A61K9/2018;;A61K9/2027;;A61K9/2027;;A61K9/2054;;A61K9/2054;;A61K31/485;;A61K31/485,A61K9/00;;A61K31/485,424/485;;424/484;;514/282;;424/488,0,0,,,,DISCONTINUED
13,WO,A2,WO 2008/075321 A2,048-812-857-590-237,2008-06-26,2008,IB 2007055299 W,2007-12-21,IN 2751DE2006 A,2006-12-21,MODIFIED-RELEASE FORMULATIONS OF AZABICYCLO DERIVATIVES,"The present invention discloses modified-release oral dosage forms of an azabicyclo derivative or its pharmaceutically acceptable salts, solvates, esters, enantiomers, diastereomers, N-oxides and polymorphs; and processes for the preparation thereof. The modified release formulation comprises an azabicyclo derivative, at least one rate-controlling polymer and at least one pharmaceutically acceptable excipient which provides therapeutically effective plasma levels of the active ingredient for a period of up to 24 hours.",RANBAXY LAB LTD;;KETKAR ANANT RAMESH;;KUMAR PRATIK;;RAMPAL ASHOK,KETKAR ANANT RAMESH;;KUMAR PRATIK;;RAMPAL ASHOK,,https://lens.org/048-812-857-590-237,Patent Application,yes,0,0,4,4,0,A61K31/403;;A61K31/403;;A61K9/0004;;A61K9/0004;;A61K9/2027;;A61K9/2027;;A61K9/2054;;A61K9/2054;;A61P1/00;;A61P11/00;;A61P13/00,A61K9/20;;A61K9/00;;A61K31/403,,0,0,,,,PENDING
14,US,A1,US 2010/0152269 A1,008-067-759-513-432,2010-06-17,2010,US 51947907 A,2007-12-21,IN 2751DE2006 A;;IB 2007055299 W,2006-12-21,MODIFIED-RELEASE FORMULATIONS OF AZABICYCLO DERIVATIVES,"The present invention discloses modified-release oral dosage forms of an azabicyclo derivative or its pharmaceutically acceptable salts, solvates, esters, enantiomers, diastereomers, N-oxides and polymorphs; and processes for the preparation thereof. The modified release formulation comprises an azabicyclo derivative, at least one rate-controlling polymer and at least one pharmaceutically acceptable excipient which provides therapeutically effective plasma levels of the active ingredient for a period of up to 24 hours.",RANBAXY LAB LTD,KETKAR ANANT RAMESH;;KUMAR PRATIK;;RAMPAL ASHOK,RANBAXY LABORATORIES LIMITED (2008-03-11),https://lens.org/008-067-759-513-432,Patent Application,yes,0,0,4,4,0,A61K31/403;;A61K31/403;;A61K9/0004;;A61K9/0004;;A61K9/2027;;A61K9/2027;;A61K9/2054;;A61K9/2054;;A61P1/00;;A61P11/00;;A61P13/00,A61K31/403;;A61P1/00;;A61P11/00;;A61P13/00,514/412,0,0,,,,DISCONTINUED
15,WO,A3,WO 2008/075321 A3,157-685-231-822-158,2008-08-21,2008,IB 2007055299 W,2007-12-21,IN 2751DE2006 A,2006-12-21,MODIFIED-RELEASE FORMULATIONS OF AZABICYCLO DERIVATIVES,"The present invention discloses modified-release oral dosage forms of an azabicyclo derivative or its pharmaceutically acceptable salts, solvates, esters, enantiomers, diastereomers, N-oxides and polymorphs; and processes for the preparation thereof. The modified release formulation comprises an azabicyclo derivative, at least one rate-controlling polymer and at least one pharmaceutically acceptable excipient which provides therapeutically effective plasma levels of the active ingredient for a period of up to 24 hours.",RANBAXY LAB LTD;;KETKAR ANANT RAMESH;;KUMAR PRATIK;;RAMPAL ASHOK,KETKAR ANANT RAMESH;;KUMAR PRATIK;;RAMPAL ASHOK,,https://lens.org/157-685-231-822-158,Search Report,yes,3,0,4,4,0,A61K31/403;;A61K31/403;;A61K9/0004;;A61K9/0004;;A61K9/2027;;A61K9/2027;;A61K9/2054;;A61K9/2054;;A61P1/00;;A61P11/00;;A61P13/00,A61K9/20;;A61K9/00;;A61K31/403,,0,0,,,,PENDING
16,WO,A3,WO 2005/037247 A3,105-006-102-092-79X,2005-06-30,2005,IB 2004003378 W,2004-10-15,IN 1285DE2003 A,2003-10-17,ORAL MATRIX FORMULATIONS OF DOXAZOSIN,"The present invention relates to extended release pharmaceutical compositions of doxazosin. The compositions include doxazosin, a low viscosity release retarding agent and a high viscosity release retarding agent.",RANBAXY LAB LTD;;JAIN GIRISH KUMAR;;KETKAR ANANT RAMESH;;RAMPAL ASHOK,JAIN GIRISH KUMAR;;KETKAR ANANT RAMESH;;RAMPAL ASHOK,,https://lens.org/105-006-102-092-79X,Search Report,yes,3,0,3,3,0,A61K9/2054;;A61P9/12,A61K9/20;;A61K47/38,,0,0,,,,PENDING
17,EP,A2,EP 1680078 A2,111-432-722-602-227,2006-07-19,2006,EP 04791705 A,2004-10-15,IB 2004003378 W;;IN 1285DE2003 A,2003-10-17,ORAL MATRIX FORMULATIONS OF DOXAZOSIN,,RANBAXY LAB LTD,JAIN GIRISH KUMAR;;KETKAR ANANT RAMESH;;RAMPAL ASHOK,,https://lens.org/111-432-722-602-227,Patent Application,yes,0,0,3,3,0,A61K9/2054;;A61P9/12,A61K9/20;;A61K47/38,,1,0,,,See references of WO 2005037247A3,DISCONTINUED
18,WO,A2,WO 2005/037247 A2,117-589-781-104-539,2005-04-28,2005,IB 2004003378 W,2004-10-15,IN 1285DE2003 A,2003-10-17,ORAL MATRIX FORMULATIONS OF DOXAZOSIN,"The present invention relates to extended release pharmaceutical compositions of doxazosin. The compositions include doxazosin, a low viscosity release retarding agent and a high viscosity release retarding agent.",RANBAXY LAB LTD;;JAIN GIRISH KUMAR;;KETKAR ANANT RAMESH;;RAMPAL ASHOK,JAIN GIRISH KUMAR;;KETKAR ANANT RAMESH;;RAMPAL ASHOK,,https://lens.org/117-589-781-104-539,Patent Application,yes,0,1,3,3,0,A61K9/2054;;A61P9/12,A61K9/20;;A61K47/38,,0,0,,,,PENDING
19,US,A1,US 2021/0088212 A1,159-413-273-039-683,2021-03-25,2021,US 201916580797 A,2019-09-24,US 201916580797 A,2019-09-24,RAIN CAP VENT FLUE ADAPTER,"A rain cap system includes a rain cap and an adapter to mount the rain cap to multiple types of gas flues or pipes. The adapter includes a first flange to mount to the rain cap and an adjustable mounting portion to mount to the gas flue. The adjustable mounting portion includes first and second moveable links having first and second surfaces with first and second edges and first and second interfacing portions, wherein the first and second edges define an opening of the adapter. The adapter includes an adjustment portion to move the first and second moveable links towards one another to decrease the size of the opening of the adapter. The adjustment portion is configured to move the first and second links away from one another to increase the size of the opening of the adapter.",AIR DISTRIBUTION TECH IP LLC,CHANDRASEKARAN SRIGANESH THANGAVEL;;PATIL VIKAS ASHOK;;SHITKANDE ATUL ANANT,CARDINAL IP HOLDING LLC (2020-05-01);;AIR DISTRIBUTION TECHNOLOGIES IP LLC (2019-09-17),https://lens.org/159-413-273-039-683,Patent Application,yes,0,2,1,1,0,F23J13/08;;F23J13/08;;F23J2900/13005;;F23L17/02,F23J13/08;;F23L17/02,,0,0,,,,DISCONTINUED
20,US,A1,US 2014/0219086 A1,003-025-352-154-872,2014-08-07,2014,US 201313758556 A,2013-02-04,US 201313758556 A,2013-02-04,SYSTEM AND METHOD FOR DISTRIBUTED NETFLOW EXPORTER WITH A SINGLE IP ENDPOINT IN A NETWORK ENVIRONMENT,"An example method for a distributed NetFlow exporter with a single IP endpoint in a network environment is provided and includes configuring a network protocol stack of an exporter with switched virtual interface (SVI) state information of an SVI associated with a switch in a network, retrieving flow data from a NetFlow cache, and communicating the flow data to a collector according to the configured network protocol stack. Although the communication bypasses the SVI, the collector perceives the flow records as being communicated by the SVI. The SVI state information includes a public Internet Protocol (IP) address and a Media Access Control (MAC) address of the SVI, where the exporter executes on an adaptor of a server in the network. The method also includes configuring a destination IP address and a destination MAC address on the exporter according to a NetFlow policy.",CANTU CESARE;;DONG XUANMING;;DEEPAK ANANT;;ASHOK SATISH;;AYALASOMAYAJULA MOHAN;;CISCO TECH INC,CANTU CESARE;;DONG XUANMING;;DEEPAK ANANT;;ASHOK SATISH;;AYALASOMAYAJULA MOHAN,CISCO TECHNOLOGY INC (2012-12-19),https://lens.org/003-025-352-154-872,Patent Application,yes,2,64,2,2,0,H04L12/4641;;H04L45/306;;H04L45/64;;H04L47/78;;H04L43/10;;H04L47/18;;H04L41/0895;;H04L41/0894;;H04L47/18;;H04L12/4641;;H04L45/306;;H04L45/64;;H04L41/0893;;H04L47/78;;H04L43/10,H04L12/56,370/231,0,0,,,,ACTIVE
21,US,B2,US 9083633 B2,085-838-684-441-651,2015-07-14,2015,US 201313758556 A,2013-02-04,US 201313758556 A,2013-02-04,System and method for distributed netflow exporter with a single IP endpoint in a network environment,"An example method for a distributed NetFlow exporter with a single IP endpoint in a network environment is provided and includes configuring a network protocol stack of an exporter with switched virtual interface (SVI) state information of an SVI associated with a switch in a network, retrieving flow data from a NetFlow cache, and communicating the flow data to a collector according to the configured network protocol stack. Although the communication bypasses the SVI, the collector perceives the flow records as being communicated by the SVI. The SVI state information includes a public Internet Protocol (IP) address and a Media Access Control (MAC) address of the SVI, where the exporter executes on an adaptor of a server in the network. The method also includes configuring a destination IP address and a destination MAC address on the exporter according to a NetFlow policy.",CANTU CESARE;;DONG XUANMING;;DEEPAK ANANT;;ASHOK SATISH;;AYALASOMAYAJULA MOHAN;;CISCO TECH INC,CANTU CESARE;;DONG XUANMING;;DEEPAK ANANT;;ASHOK SATISH;;AYALASOMAYAJULA MOHAN,CISCO TECHNOLOGY INC (2012-12-19),https://lens.org/085-838-684-441-651,Granted Patent,yes,2,2,2,2,0,H04L12/4641;;H04L45/306;;H04L45/64;;H04L47/78;;H04L43/10;;H04L47/18;;H04L41/0895;;H04L41/0894;;H04L47/18;;H04L12/4641;;H04L45/306;;H04L45/64;;H04L41/0893;;H04L47/78;;H04L43/10,H04L1/00;;H04L12/801,,3,0,,,"Cisco Systems, Inc., ""Cisco Catalyst 6500 Series Virtual Switching System"" White Paper, Dec. 2012, 55 pages.;;Cisco Systems, Inc., ""Cisco IOS Switching Services Configuration Guide: Configuring NetFlow,"" Release 12.1, Jan. 8, 2001, 8 pages.;;Cisco Systems, Inc., ""Switch Virtual Interface for Cisco Integrated Services Routers,"" White Paper, © 2011-2012, 10 pages; http://www.cisco.com/en/US/prod/collateral/routers/ps5853/prod-white-paper0900aecd8064c9f4-ps380-Products-White-Paper.html.",ACTIVE
22,WO,A2,WO 2008/122994 A2,000-835-747-398-359,2008-10-16,2008,IN 2008000234 W,2008-04-08,IN 702MU2007 A,2007-04-09,NOVEL STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF,"The present invention discloses novel stable oral pharmaceutical compositions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, the said Clopidogrel bisulfate is crystalline Form 1 and the composition additionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceutical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical stability to the composition.",USV LTD;;HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,,https://lens.org/000-835-747-398-359,Patent Application,yes,0,3,8,8,0,A61K9/2009;;A61K9/2013;;A61K9/2027;;A61K9/2054;;A61K9/2866;;A61K31/4365;;A61P7/02;;A61P9/10;;A61K31/4365;;A61K47/38;;A61K9/2009;;A61K31/4365;;A61K9/2054;;A61K9/2013;;A61K9/2866;;A61K9/2027,A61K9/20;;A61K9/28;;A61K31/4365,,0,0,,,,PENDING
23,AU,A1,AU 2002/328176 A1,103-762-371-346-947,2004-03-11,2004,AU 2002/328176 A,2002-08-26,IB 0203435 W,2002-08-26,AZOLE DERIVATIVES AS ANTIFUNGAL AGENTS,,RANBAXY LAB LTD,SETHI SACHIN;;RATTAN ASHOK;;SALMAN MOHAMMAD;;SATTIGERI JITENDRA ANANT;;KATOCH RITA,,https://lens.org/103-762-371-346-947,Patent Application,no,0,0,8,8,0,A61P31/10;;C07D249/08;;C07D249/08;;C07D401/12;;C07D401/12;;C07D403/12;;C07D403/12;;C07D405/12;;C07D405/12;;C07D409/12;;C07D409/12,C07D249/08;;C07D249/12;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D521/00,,0,0,,,,DISCONTINUED
24,AU,A1,AU 2002/334270 A1,084-292-651-008-773,2004-03-11,2004,AU 2002/334270 A,2002-09-12,IB 0203435 W;;IB 0203740 W,2002-08-26,AZOLE DERIVATIVES AS ANTIFUNGAL AGENTS,,RANBAXY LABORATORIES LTD,SALMAN MOHAMMAD;;SATTIGERI JITENDRA ANANT;;KATOCH RITA;;SETHI SACHIN;;RATTAN ASHOK,,https://lens.org/084-292-651-008-773,Patent Application,no,0,0,8,8,0,A61P31/10;;C07D249/08;;C07D249/08;;C07D401/12;;C07D401/12;;C07D403/12;;C07D403/12;;C07D405/12;;C07D405/12;;C07D409/12;;C07D409/12,C07D249/08;;C07D249/12;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D521/00,,0,0,,,,DISCONTINUED
25,CN,A,CN 1671717 A,064-266-303-435-125,2005-09-21,2005,CN 02829699 A,2002-09-12,IB 0203435 W,2002-08-26,Azole derivatives as antifungal agents,,RANBAXY LAB LTD,MOHAMMAD SALMAN;;ANANT SATTIGERI JITENDRA;;RITA KATOCH;;SACHIN SETHI;;ASHOK RATTAN,,https://lens.org/064-266-303-435-125,Patent Application,no,0,1,8,8,0,A61P31/10;;C07D249/08;;C07D249/08;;C07D401/12;;C07D401/12;;C07D403/12;;C07D403/12;;C07D405/12;;C07D405/12;;C07D409/12;;C07D409/12,C07D249/08;;C07D249/12;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D521/00,,0,0,,,,DISCONTINUED
26,CA,A1,CA 2683611 A1,195-811-609-762-12X,2008-10-16,2008,CA 2683611 A,2008-04-08,IN 702MU2007 A;;IN 2008000234 W,2007-04-09,NOVEL STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF,"The present invention discloses novel stable oral pharmaceutical composit ions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, th e said Clopidogrel bisulfate is crystalline Form 1 and the composition addit ionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceu tical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical st ability to the composition.",USV LTD,HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,,https://lens.org/195-811-609-762-12X,Patent Application,no,0,0,8,8,0,A61K9/2009;;A61K9/2013;;A61K9/2027;;A61K9/2054;;A61K9/2866;;A61K31/4365;;A61P7/02;;A61P9/10;;A61K31/4365;;A61K47/38;;A61K9/2009;;A61K31/4365;;A61K9/2054;;A61K9/2013;;A61K9/2866;;A61K9/2027,A61K9/20;;A61K9/28;;A61K31/4365,,0,0,,,,DISCONTINUED
27,WO,A2,WO 2009/066315 A2,190-880-551-018-441,2009-05-28,2009,IN 2008000493 W,2008-08-07,IN 1533MU2007 A,2007-08-08,SUSTAINED RELEASE COMPOSITIONS OF TRIMETAZIDINE AND PROCESS FOR PREPARATION THEREOF,Disclosed herein are sustained release pharmaceutical compositions comprising Trimetazidine or a pharmaceutically acceptable salt thereof and release modifying agents together with suitable pharmaceutically acceptable excipients. The sustained release pharmaceutical compositions of the present invention are characterized by the absence of cellulose and/or their derivatives as release modifying agents.,USV LTD;;HEGDE DEEPAK ANANT;;SHENOY SANDHYA RAJENDRA;;BHATT HARISH TULSIDUTT;;OMRAY ASHOK,HEGDE DEEPAK ANANT;;SHENOY SANDHYA RAJENDRA;;BHATT HARISH TULSIDUTT;;OMRAY ASHOK,,https://lens.org/190-880-551-018-441,Patent Application,yes,0,21,4,4,0,A61K9/2031;;A61K9/2009;;A61K9/2027;;A61K9/205;;A61K31/495;;A61P9/10,,,1,0,,,See references of EP 2187874A2,PENDING
28,WO,A1,WO 2004/018486 A1,168-949-256-058-374,2004-03-04,2004,IB 0203740 W,2002-09-12,IB 0203435 W,2002-08-26,AZOLE DERIVATIVES AS ANTIFUNGAL AGENTS,"The present invention relates to novel azole derivatives of Formula I, as potential antifungal agents.This invention also relates to pharmaceutical compositions containing the compounds of the present invention and their use in treating and / or preventing the fungal infections in mammals, preferably humans.",RANBAXY LAB LTD;;SALMAN MOHAMMAD;;SATTIGERI JITENDRA ANANT;;KATOCH RITA;;SETHI SACHIN;;RATTAN ASHOK,SALMAN MOHAMMAD;;SATTIGERI JITENDRA ANANT;;KATOCH RITA;;SETHI SACHIN;;RATTAN ASHOK,,https://lens.org/168-949-256-058-374,Patent Application,yes,6,0,8,8,0,A61P31/10;;C07D249/08;;C07D249/08;;C07D401/12;;C07D401/12;;C07D403/12;;C07D403/12;;C07D405/12;;C07D405/12;;C07D409/12;;C07D409/12,C07D249/08;;C07D249/12;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D521/00,,2,1,156-868-502-900-409,8998838;;10.1248/cpb.44.314,"KITAZAKI T ET AL: ""OPTICALLY ACTIVE ANTIFUNGAL AZOLES. VI.1) SYNTHESIS AND ANTIFUNGAL ACTIVITY OF N-U(1R,2R)-2-(2,4-DIFLUOROPHENYL)-2-HYDROXY-1-METHYL-3-(1 H-1,2,4-TRIAZOL-1-YL)PROPYL-N'-(4-SUBSTITUTED PHENYL)-3(2H,4H)- 1,2,4-TRIAZOLONES AND 5(1H,4H)-TETRAZOLONES"", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN. TOKYO, JP, vol. 44, no. 2, 1996, pages 314 - 327, XP002067032, ISSN: 0009-2363;;See also references of EP 1546158A1",PENDING
29,EP,A2,EP 2187874 A2,055-904-944-244-596,2010-05-26,2010,EP 08852448 A,2008-08-07,IN 2008000493 W;;IN 1533MU2007 A,2007-08-08,SUSTAINED RELEASE COMPOSITIONS OF TRIMETAZIDINE AND PROCESS FOR PREPARATION THEREOF,,USV LTD,HEGDE DEEPAK ANANT;;SHENOY SANDHYA RAJENDRA;;BHATT HARISH TULSIDUTT;;OMRAY ASHOK,,https://lens.org/055-904-944-244-596,Patent Application,yes,0,0,4,4,0,A61K9/2031;;A61K9/2009;;A61K9/2027;;A61K9/205;;A61K31/495;;A61P9/10,A61K9/22,,1,0,,,"AVINASH D.: ""Formulation and Evaluation of Sustained release Tablets of Trimetazidine Dihydrochloride using various Polymers"", AAPS ANNUAL MEETING AND EXPOSITION, 31 October 2006 (2006-10-31), pages 1 - 2, XP003032101",DISCONTINUED
30,WO,A3,WO 2009/066315 A3,111-140-718-340-75X,2009-09-24,2009,IN 2008000493 W,2008-08-07,IN 1533MU2007 A,2007-08-08,SUSTAINED RELEASE COMPOSITIONS OF TRIMETAZIDINE AND PROCESS FOR PREPARATION THEREOF,Disclosed herein are sustained release pharmaceutical compositions comprising Trimetazidine or a pharmaceutically acceptable salt thereof and release modifying agents together with suitable pharmaceutically acceptable excipients. The sustained release pharmaceutical compositions of the present invention are characterized by the absence of cellulose and/or their derivatives as release modifying agents.,USV LTD;;HEGDE DEEPAK ANANT;;SHENOY SANDHYA RAJENDRA;;BHATT HARISH TULSIDUTT;;OMRAY ASHOK,HEGDE DEEPAK ANANT;;SHENOY SANDHYA RAJENDRA;;BHATT HARISH TULSIDUTT;;OMRAY ASHOK,,https://lens.org/111-140-718-340-75X,Search Report,yes,3,0,4,4,0,A61K9/2031;;A61K9/2009;;A61K9/2027;;A61K9/205;;A61K31/495;;A61P9/10,A61K9/22;;A61K31/495;;A61P9/10,,2,1,074-595-882-022-359,11992677;;10.1016/s0168-3659(02)00031-7,"KRISHNAIAH Y S R ET AL: ""Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride"", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 81, no. 1-2, 17 May 2002 (2002-05-17), pages 45 - 56, XP004351102, ISSN: 0168-3659;;See also references of EP 2187874A2",PENDING
31,EP,A2,EP 2155168 A2,007-713-068-538-136,2010-02-24,2010,EP 08738409 A,2008-04-08,IN 2008000234 W;;IN 702MU2007 A,2007-04-09,STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF,,USV LTD,HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,,https://lens.org/007-713-068-538-136,Patent Application,yes,1,0,8,8,0,A61K9/2009;;A61K9/2013;;A61K9/2027;;A61K9/2054;;A61K9/2866;;A61K31/4365;;A61P7/02;;A61P9/10;;A61K31/4365;;A61K47/38;;A61K9/2009;;A61K31/4365;;A61K9/2054;;A61K9/2013;;A61K9/2866;;A61K9/2027,A61K9/28;;A61K9/20;;A61K31/4365,,0,0,,,,DISCONTINUED
32,EP,A1,EP 1546158 A1,056-604-459-987-89X,2005-06-29,2005,EP 02807729 A,2002-09-12,IB 0203740 W;;IB 0203435 W,2002-08-26,AZOLE DERIVATIVES AS ANTIFUNGAL AGENTS,,RANBAXY LAB LTD,SALMAN MOHAMMAD;;SATTIGERI JITENDRA ANANT;;KATOCH RITA;;SETHI SACHIN;;RATTAN ASHOK,,https://lens.org/056-604-459-987-89X,Patent Application,yes,3,0,8,8,0,C07D249/08;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;A61P31/10;;C07D249/08;;C07D403/12;;C07D409/12;;C07D405/12;;C07D401/12,C07D249/08;;C07D249/12;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D521/00,,2,1,156-868-502-900-409,8998838;;10.1248/cpb.44.314,"KITAZAKI T ET AL: ""OPTICALLY ACTIVE ANTIFUNGAL AZOLES. VI.1) SYNTHESIS AND ANTIFUNGAL ACTIVITY OF N-U(1R,2R)-2-(2,4-DIFLUOROPHENYL)-2-HYDROXY-1-METHYL-3-(1 H-1,2,4-TRIAZOL-1-YL)PROPYL-N'-(4-SUBSTITUTED PHENYL)-3(2H,4H)- 1,2,4-TRIAZOLONES AND 5(1H,4H)-TETRAZOLONES"", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN. TOKYO, JP, vol. 44, no. 2, 1996, pages 314 - 327, XP002067032, ISSN: 0009-2363;;See also references of WO 2004018486A1",DISCONTINUED
33,BR,A2,BR PI0815602 A2,071-987-820-199-267,2015-03-03,2015,BR PI0815602 A,2008-08-07,IN 1533MU2007 A;;IN 2008000493 W,2007-08-08,COMPOSIÇÕES DE LIBERAÇÃO PROLONGADA DE TRIMETAZIDINA E PROCESSO PARA A PREPARAÇÃO DAS MESMAS,,USV LTD,HEDGE DEEPAK ANANT;;SHENOY SANDHYA RAJENDRA;;BHATT HARISH TULSIDUTT;;OMRAY ASHOK,,https://lens.org/071-987-820-199-267,Patent Application,no,0,0,4,4,0,A61K9/2031;;A61K9/2009;;A61K9/2027;;A61K9/205;;A61K31/495;;A61P9/10,A61K9/22;;A61K31/495;;A61P9/10,,0,0,,,,DISCONTINUED
34,WO,A3,WO 2008/122994 A3,176-637-456-955-739,2009-06-11,2009,IN 2008000234 W,2008-04-08,IN 702MU2007 A,2007-04-09,STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF,"The present invention discloses novel stable oral pharmaceutical compositions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, the said Clopidogrel bisulfate is crystalline Form 1 and the composition additionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceutical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical stability to the composition.",USV LTD;;HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,,https://lens.org/176-637-456-955-739,Search Report,yes,5,0,8,8,0,A61K9/2009;;A61K9/2013;;A61K9/2027;;A61K9/2054;;A61K9/2866;;A61K31/4365;;A61P7/02;;A61P9/10;;A61K31/4365;;A61K47/38;;A61K9/2009;;A61K31/4365;;A61K9/2054;;A61K9/2013;;A61K9/2866;;A61K9/2027,A61K9/20;;A61K9/28;;A61K31/4365,,0,0,,,,PENDING
35,KR,A,KR 20100016295 A,117-745-256-379-106,2010-02-12,2010,KR 20097023224 A,2008-04-08,IN 702MU2007 A,2007-04-09,NOVEL STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF,"The present invention discloses novel stable oral pharmaceutical compositions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, the said Clopidogrel bisulfate is crystalline Form 1 and the composition additionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceutical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical stability to the composition.",USV LTD,HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,,https://lens.org/117-745-256-379-106,Patent Application,no,0,1,8,8,0,A61K9/2009;;A61K9/2013;;A61K9/2027;;A61K9/2054;;A61K9/2866;;A61K31/4365;;A61P7/02;;A61P9/10;;A61K31/4365;;A61K47/38;;A61K9/2009;;A61K31/4365;;A61K9/2054;;A61K9/2013;;A61K9/2866;;A61K9/2027,A61K47/38;;A61P7/02,,0,0,,,,DISCONTINUED
36,BR,A2,BR PI0810168 A2,168-207-860-823-818,2014-12-30,2014,BR PI0810168 A,2008-04-08,IN 702MU2007 A;;IN 2008000234 W,2007-04-09,COMPOSIÇÕES FARMACÊUTICAS DE BISSULFATO DE CLOPIDOGREL E PROCESSOS DE PREPARAÇÃO DAS MESMAS,,USV LTD,HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,,https://lens.org/168-207-860-823-818,Patent Application,no,0,0,8,8,0,A61K9/2009;;A61K9/2013;;A61K9/2027;;A61K9/2054;;A61K9/2866;;A61K31/4365;;A61P7/02;;A61P9/10;;A61K31/4365;;A61K47/38;;A61K9/2009;;A61K31/4365;;A61K9/2054;;A61K9/2013;;A61K9/2866;;A61K9/2027,A61K9/20;;A61K9/28;;A61K31/4365,,0,0,,,,DISCONTINUED
37,US,A1,US 2010/0086590 A1,024-282-387-860-08X,2010-04-08,2010,US 57581309 A,2009-10-08,IN 702MU2007 A;;IN 2008000234 W,2007-04-09,NOVEL STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF,"The present invention discloses novel stable oral pharmaceutical compositions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, the said Clopidogrel bisulfate is crystalline Form 1 and the composition additionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceutical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical stability to the composition.",USV LTD,HEGDE DEEPAK ANANT;;CHOTHE SANTOSH SADASHIV;;GHOGARI IMRAN SHAKUR;;OMRAY ASHOK,USV LIMITED (2009-11-17),https://lens.org/024-282-387-860-08X,Patent Application,yes,28,2,8,8,0,A61K9/2009;;A61K9/2013;;A61K9/2027;;A61K9/2054;;A61K9/2866;;A61K31/4365;;A61P7/02;;A61P9/10;;A61K31/4365;;A61K47/38;;A61K9/2009;;A61K31/4365;;A61K9/2054;;A61K9/2013;;A61K9/2866;;A61K9/2027,A61K31/4365;;A61K9/20;;A61P9/10,424/464;;514/301;;427/2.14;;424/400,0,0,,,,DISCONTINUED
38,WO,A1,WO 2004/018485 A1,183-981-774-581-353,2004-03-04,2004,IB 0203435 W,2002-08-26,IB 0203435 W,2002-08-26,AZOLE DERIVATIVES AS ANTIFUNGAL AGENTS,"The present invention relates to novel azole derivatives of Formula (I), as potential antifungal agents. This invention also relates to pharmaceutical compositions containing the compounds of the present invention and their use in treating and / or preventing the fungal infections in mammals, preferably humans.",RANBAXY LAB LTD;;SALMAN MOHAMMAD;;SATTIGERI JITENDRA ANANT;;KATOCH RITA;;SETHI SACHIN;;RATTAN ASHOK,SALMAN MOHAMMAD;;SATTIGERI JITENDRA ANANT;;KATOCH RITA;;SETHI SACHIN;;RATTAN ASHOK,,https://lens.org/183-981-774-581-353,Patent Application,yes,6,7,8,8,0,A61P31/10;;C07D249/08;;C07D249/08;;C07D401/12;;C07D401/12;;C07D403/12;;C07D403/12;;C07D405/12;;C07D405/12;;C07D409/12;;C07D409/12,C07D249/08;;C07D249/12;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D521/00,,1,1,156-868-502-900-409,8998838;;10.1248/cpb.44.314,"KITAZAKI T ET AL: ""OPTICALLY ACTIVE ANTIFUNGAL AZOLES. VI.1) SYNTHESIS AND ANTIFUNGAL ACTIVITY OF N-U(1R,2R)-2-(2,4-DIFLUOROPHENYL)-2-HYDROXY-1-METHYL-3-(1 H-1,2,4-TRIAZOL-1-YL)PROPYL-N'-(4-SUBSTITUTED PHENYL)-3(2H,4H)- 1,2,4-TRIAZOLONES AND 5(1H,4H)-TETRAZOLONES"", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN. TOKYO, JP, vol. 44, no. 2, 1996, pages 314 - 327, XP002067032, ISSN: 0009-2363",PENDING
39,US,A1,US 2018/0042820 A1,126-204-506-591-99X,2018-02-15,2018,US 201715792879 A,2017-10-25,US 201715792879 A;;US 201414478091 A;;US 54428204 A;;US 2004/0003242 W;;US 47969003 P;;US 44537603 P,2003-02-05,Toothpaste Compositions with Reduced Abrasivity,"Toothpaste compositions are disclosed. The toothpaste composition comprises a binder; a surface active agent; an abrasive; a humectant; and water; in which: (1) the abrasive is silica, the composition additionally comprises a silica thickener, and the composition comprises 1 to 7 wt % of the silica thickener, less than 15 wt % of the silica abrasive, 45 to 70 wt % water, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder; or (2) the abrasive is silica, the composition additionally comprises a silica thickener, the composition comprises 2 to 22 wt % total silica, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder, and the composition additionally comprises about 0.1 to 8.0 wt % of non-colloidal microcrystalline cellulose, colloidal microcrystalline cellulose, or a mixture thereof; or (3) the binder is a calcium based abrasive, the binder is a cellulose gum, and the composition comprises 25 to 55 wt % of the calcium based abrasive, 35 to 60 wt % water, 0.8 to 3.0 wt % of the surface active agent, and 1.0 to 3.0 wt % of the binder.",FMC CORP,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,DUPONT NUTRITION USA INC (2017-11-01),https://lens.org/126-204-506-591-99X,Patent Application,yes,0,1,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K6/00;;A61K8/19;;A61K8/25;;A61K8/73;;A61Q11/00,,0,0,,,,DISCONTINUED
40,US,A1,US 2014/0377191 A1,140-454-526-703-61X,2014-12-25,2014,US 201414478091 A,2014-09-05,US 201414478091 A;;US 54428204 A;;US 2004/0003242 W;;US 44537603 P;;US 47969003 P,2003-02-05,Toothpaste Compositions with Reduced Abrasivity,"Toothpaste compositions are disclosed. The toothpaste composition comprises a binder; a surface active agent; an abrasive; a humectant; and water; in which: (1) the abrasive is silica, the composition additionally comprises a silica thickener, and the composition comprises 1 to 7 wt % of the silica thickener, less than 15 wt % of the silica abrasive, 45 to 70 wt % water, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder; or (2) the abrasive is silica, the composition additionally comprises a silica thickener, the composition comprises 2 to 22 wt % total silica, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder, and the composition additionally comprises about 0.1 to 8.0 wt % of non-colloidal microcrystalline cellulose, colloidal microcrystalline cellulose, or a mixture thereof; or (3) the binder is a calcium based abrasive, the binder is a cellulose gum, and the composition comprises 25 to 55 wt % of the calcium based abrasive, 35 to 60 wt % water, 0.8 to 3.0 wt % of the surface active agent, and 1.0 to 3.0 wt % of the binder.",FMC CORP,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,DUPONT NUTRITION USA INC (2017-11-01),https://lens.org/140-454-526-703-61X,Patent Application,yes,0,4,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K8/19;;A61K6/00;;A61K8/25;;A61K8/73;;A61Q11/00,424/49,0,0,,,,EXPIRED
41,WO,A3,WO 2004/071321 A3,038-421-376-213-149,2005-05-19,2005,US 2004/0003242 W,2004-02-04,US 44537603 P;;US 47969003 P,2003-02-05,TOOTHPASTE COMPOSITIONS WITH REDUCED ABRASIVITY,"Toothpaste compositions are disclosed. The toothpaste composition comprises a binder; a surface active agent; an abrasive; a humectant; and water; in which: (1) the abrasive is silica, the composition additionally comprises a silica thickener, and the composition comprises 1 to 7 wt % of the silica thickener, less than 15 wt % of the silica abrasive, 45 to 70 wt % water, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder; or (2) the abrasive is silica, the composition additionally comprises a silica thickener, the composition comprises 2 to 22 wt % total silica, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder, and the composition additionally comprises about 0.1 to 8.0 wt % of non-colloidal microcrystalline cellulose, colloidal microcrystalline cellulose, or a mixture thereof; or (3) the binder is a calcium based abrasive, the binder is a cellulose gum, and the composition comprises 25 to 55 wt % of the calcium based abrasive, 35 to 60 wt % water, 0.8 to 3.0 wt % of the surface active agent, and 1.0 to 3.0 wt % of the binder.",FMC CORP;;GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,,https://lens.org/038-421-376-213-149,Search Report,yes,2,0,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K6/00;;A61K8/19;;A61K8/25;;A61K8/73;;A61Q11/00,,0,0,,,,PENDING
42,US,B2,US 9827170 B2,054-762-466-898-466,2017-11-28,2017,US 201414478091 A,2014-09-05,US 201414478091 A;;US 54428204 A;;US 2004/0003242 W;;US 44537603 P;;US 47969003 P,2003-02-05,Toothpaste compositions with reduced abrasivity,"Toothpaste compositions are disclosed. The toothpaste composition comprises a binder; a surface active agent; an abrasive; a humectant; and water; in which: (1) the abrasive is silica, the composition additionally comprises a silica thickener, and the composition comprises 1 to 7 wt % of the silica thickener, less than 15 wt % of the silica abrasive, 45 to 70 wt % water, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder; or (2) the abrasive is silica, the composition additionally comprises a silica thickener, the composition comprises 2 to 22 wt % total silica, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder, and the composition additionally comprises about 0.1 to 8.0 wt % of non-colloidal microcrystalline cellulose, colloidal microcrystalline cellulose, or a mixture thereof; or (3) the binder is a calcium based abrasive, the binder is a cellulose gum, and the composition comprises 25 to 55 wt % of the calcium based abrasive, 35 to 60 wt % water, 0.8 to 3.0 wt % of the surface active agent, and 1.0 to 3.0 wt % of the binder.",FMC CORP,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,DUPONT NUTRITION USA INC (2017-11-01),https://lens.org/054-762-466-898-466,Granted Patent,yes,5,1,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K6/00;;A61K8/19;;A61K8/25;;A61K8/73;;A61Q11/00,,0,0,,,,EXPIRED
43,CN,B,CN 101683312 B,142-727-531-109-774,2013-01-16,2013,CN 200910168690 A,2004-02-04,US 44537603 P;;US 47969003 P,2003-02-05,Toothpaste compositions with reduced abrasivity,,FMC CORP,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,,https://lens.org/142-727-531-109-774,Granted Patent,no,0,0,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K8/73;;A61K6/00;;A61K8/19;;A61K8/25;;A61Q11/00,,0,0,,,,EXPIRED
44,BR,A,BR PI0407065 A,171-165-992-763-322,2006-01-17,2006,BR PI0407065 A,2004-02-04,US 44537603 P;;US 47969003 P;;US 2004/0003242 W,2003-02-05,Composição de pasta de dentes,"""COMPOSIçãO DE PASTA DE DENTES"". São divulgadas composições de pasta de dentes. A composição de pasta de dentes compreende um aglutinante; um agente ativo na superfície; um abrasivo; um umectante; e água; na qual: (1) o abrasivo é sílica, a composição compreende em adição um espessante de sílica, e a composição compreende de 1 a 7% em peso de espessante de sílica, menos de 15% em peso de abrasivo de sílica, de 45 a 70% em peso de água, de 0,8 a 3.0% em peso de um agente ativo na superfície; de 0,05 a 3.0% em peso de aglutinante; ou (2) o abrasivo é sílica, a composição compreende em adição um espessante de sílica, a composição compreende de 2 a 22% em peso de sílica total, de 0,8 a 3,0% em peso de um agente ativo na superfície; de 0,05 a 3,0% em peso de aglutinante, e a composição compreende em adição de cerca de 0, 1 a 8,0% em peso de celulose microcristalina não-coloidal, celulose microcristalina coloidal, ou uma mistura das mesmas; ou (3) o aglutinante é um abrasivo à base de cálcio, o aglutinante é uma goma de celulose, e a composição compreende de 25 a 55% em peso de abrasivo à base de cálcio, de 35 a 60% em peso de água, de 0,8 a 3,0% em peso de agente ativo na superfície, e de 1.0 a 3,0% em peso de aglutinante.",FMC CORP,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,,https://lens.org/171-165-992-763-322,Patent Application,no,0,0,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K6/00;;A61K8/19;;A61K8/25;;A61K8/73;;A61Q11/00,,0,0,,,,DISCONTINUED
45,US,B2,US 9072658 B2,164-482-328-941-472,2015-07-07,2015,US 54428204 A,2004-02-04,US 44537603 P;;US 47969003 P;;US 2004/0003242 W;;US 54428204 A,2003-02-05,Toothpaste compositions with reduced abrasivity,"Toothpaste compositions are disclosed. The toothpaste composition comprises a binder; a surface active agent; an abrasive; a humectant; and water, in which: (1) the abrasive is silica, the composition additionally comprises a silica thickener, and the composition comprises 1 to 7 wt % of the silica thickener, less than 15 wt % of the silica abrasive, 45 to 70 wt % water, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder, or (2) the abrasive is silica, the composition additionally comprises a silica thickener, the composition comprises 2 to 22 wt % total silica, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder, and the composition additionally comprises about 0.1 to 8.0 wt % of non-colloidal microcrystalline cellulose, colloidal microcrystalline cellulose, or a mixture thereof; or (3) the binder is a calcium based abrasive, the binder is a cellulose gum, and the composition comprises 25 to 55 wt % of the calcium based abrasive, 35 to 60 wt % water, 0.8 to 3.0 wt % of the surface active agent, and 1.0 to 3.0 wt % of the binder.",GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT;;FMC CORP,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,FMC CORPORATION (2006-03-28);;DUPONT NUTRITION USA INC (2017-11-01),https://lens.org/164-482-328-941-472,Granted Patent,yes,41,3,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K8/00;;A61K6/00;;A61K8/19;;A61K8/25;;A61K8/73;;A61Q11/00,,1,0,,,"Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration-Dated Mar. 1, 2005-International Application No. PCT/US04/03242.",ACTIVE
46,CN,A,CN 101683312 A,129-390-252-447-779,2010-03-31,2010,CN 200910168690 A,2004-02-04,US 44537603 P;;US 47969003 P,2003-02-05,Toothpaste compositions with reduced abrasivity,"Toothpaste compositions are disclosed. The toothpaste composition comprises a binder; a surface active agent; an abrasive; a humectant; and water; in which: (1) the abrasive is silica, the composition additionally comprises a silica thickener, and the composition comprises 1 to 7 wt % of the silica thickener, less than 15 wt % of the silica abrasive, 45 to 70 wt % water, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder; or (2) the abrasive is silica, the composition additionally comprises a silica thickener, the composition comprises 2 to 22 wt % total silica, 0.8 to 3.0wt % of a surface active agent; 0.05 to 3.0 wt % the binder, and the composition additionally comprises about 0.1 to 8.0 wt % of non-colloidal microcrystalline cellulose, colloidal microcrystalline cellulose, or a mixture thereof; or (3) the binder is a calcium based abrasive, the binder is a cellulose gum, and the composition comprises 25 to 55 wt % of the calcium based abrasive, 35 to 60 wt % water, 0.8 to 3.0 wt % of the surface active agent, and 1.0 to 3.0 wt % of the binder.",FMC CORP,KAMALAKANT GADKARI VIJAY;;BHALCHANDRA RANDIVE VINAYAK;;RAMANAN VENKAT MAHALINGAM;;ASHOK BETRABET NAMITA;;ANANT KADAM SITARAM,,https://lens.org/129-390-252-447-779,Patent Application,no,0,1,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K8/73;;A61K6/00;;A61K8/19;;A61K8/25;;A61Q11/00,,0,0,,,,EXPIRED
47,CN,C,CN 100544700 C,021-175-860-143-754,2009-09-30,2009,CN 200480003470 A,2004-02-04,US 44537603 P,2003-02-05,Toothpaste compositions with reduced abrasiveness,,FMC CORP,KAMALAKANT GADKARI VIJAY;;BHALCHANDRA RANDIVE VINAYAK;;RAMANAN VENKAT MAHALINGAM;;ASHOK BETRABET NAMITA;;ANANT KADAM SITARAM,,https://lens.org/021-175-860-143-754,Granted Patent,no,0,1,2,13,0,,A61K8/25,,0,0,,,,EXPIRED
48,WO,A2,WO 2004/071321 A2,061-377-064-716-001,2004-08-26,2004,US 2004/0003242 W,2004-02-04,US 44537603 P;;US 47969003 P,2003-02-05,TOOTHPASTE COMPOSITIONS WITH REDUCED ABRASIVITY,"Toothpaste compositions are disclosed. The toothpaste composition comprises a binder; a surface active agent; an abrasive; a humectant; and water; in which: (1) the abrasive is silica, the composition additionally comprises a silica thickener, and the composition comprises 1 to 7 wt % of the silica thickener, less than 15 wt % of the silica abrasive, 45 to 70 wt % water, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder; or (2) the abrasive is silica, the composition additionally comprises a silica thickener, the composition comprises 2 to 22 wt % total silica, 0.8 to 3.0 wt % of a surface active agent; 0.05 to 3.0 wt % the binder, and the composition additionally comprises about 0.1 to 8.0 wt % of non-colloidal microcrystalline cellulose, colloidal microcrystalline cellulose, or a mixture thereof; or (3) the binder is a calcium based abrasive, the binder is a cellulose gum, and the composition comprises 25 to 55 wt % of the calcium based abrasive, 35 to 60 wt % water, 0.8 to 3.0 wt % of the surface active agent, and 1.0 to 3.0 wt % of the binder.",FMC CORP;;GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,GADKARI VIJAY KAMALAKANT;;RANDIVE VINAYAK BHALCHANDRA;;VENKAT MAHALINGAM RAMANAN;;BETRABET NAMITA ASHOK;;KADAM SITARAM ANANT,,https://lens.org/061-377-064-716-001,Patent Application,yes,0,26,11,13,0,A61K6/00;;A61K6/00;;A61K8/19;;A61K8/19;;A61K8/25;;A61K8/25;;A61K8/731;;A61K8/731;;A61K2800/10;;A61K2800/412;;A61K2800/412;;A61K2800/5422;;A61K2800/5422;;A61Q11/00;;A61Q11/00,A61K6/00;;A61K8/19;;A61K8/25;;A61K8/73;;A61Q11/00,,0,0,,,,PENDING
49,WO,A2,WO 2011/048612 A2,155-605-948-154-77X,2011-04-28,2011,IN 2010000671 W,2010-10-08,IN 2387MU2009 A,2009-10-14,PROCESSES FOR THE PREPARATION OF PROPARGYLATED AMINOINDANS OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF,"The present invention relates to preparation of a compound of formula (I), wherein R 1 = H or formula (b) and R 2 is C 1 -C 4 alkyl, R 3 = H or C 1 -C 4 alkyl comprising: a) reacting an indanone derivative or a salt thereof of formula (II) with the propargyl amine or a salt thereof of formula (III) in the presence of a Lewis acid; and b) subjecting the resultant reaction mixture to reduction",GLENMARK GENERICS LTD;;THANEDAR AMIT ANANT;;DESHMUKH SHEKHAR ASHOK;;ZOPE SUNIL SUDHAKAR;;KELKAR LAXMIKANT MADHUKAR;;KOILPILLAI JOSEPH PRABAHAR;;GAJERA JITENDRA MAGANBHAI,THANEDAR AMIT ANANT;;DESHMUKH SHEKHAR ASHOK;;ZOPE SUNIL SUDHAKAR;;KELKAR LAXMIKANT MADHUKAR;;KOILPILLAI JOSEPH PRABAHAR;;GAJERA JITENDRA MAGANBHAI,,https://lens.org/155-605-948-154-77X,Patent Application,yes,0,2,2,2,0,A61P25/16;;C07C209/28;;C07C211/42;;C07C2602/08,C07C211/42,,0,0,,,,PENDING
50,WO,A3,WO 2011/048612 A3,021-915-572-748-610,2011-08-11,2011,IN 2010000671 W,2010-10-08,IN 2387MU2009 A,2009-10-14,PROCESS FOR PREPARATION OF PROPARGYLATED AMINOINDANS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF,"A process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof, comprises: a) reacting an indanone derivative or a salt thereof with propargyl amine or a salt thereof in the presence of a Lewis acid; b) subjecting the resultant reaction mixture to reduction.",GLENMARK GENERICS LTD;;THANEDAR AMIT ANANT;;DESHMUKH SHEKHAR ASHOK;;ZOPE SUNIL SUDHAKAR;;KELKAR LAXMIKANT MADHUKAR;;KOILPILLAI JOSEPH PRABAHAR;;GAJERA JITENDRA MAGANBHAI,THANEDAR AMIT ANANT;;DESHMUKH SHEKHAR ASHOK;;ZOPE SUNIL SUDHAKAR;;KELKAR LAXMIKANT MADHUKAR;;KOILPILLAI JOSEPH PRABAHAR;;GAJERA JITENDRA MAGANBHAI,,https://lens.org/021-915-572-748-610,Search Report,yes,5,0,2,2,0,A61P25/16;;C07C209/28;;C07C211/42;;C07C2602/08,C07C211/42;;A61K31/135;;A61P25/16;;C07C209/22;;C07C269/06;;C07C271/44,,0,0,,,,PENDING
51,WO,A1,WO 2014/102816 A1,082-825-625-051-90X,2014-07-03,2014,IN 2013000790 W,2013-12-23,IN 3624MU2012 A;;US 201361765005 P;;IN 1380MU2013 A,2012-12-26,PROCESS FOR PREPARATION OF TELAPREVIR AND INTERMEDIATES,The present invention relates to a novel process for preparation of telaprevir.,GLENMARK PHARMACEUTICALS LTD ; GLENMARK GENERICS LTD,BHIRUD SHEKHAR BHASKAR;;BHUSHAN KUMAR HARI;;DESHMUKH SHEKHAR ASHOK;;KADAM AMOL ANANT;;CHAND PREM;;ZOPE SUNIL SUDHAKAR;;SINHA SUKUMAR;;ANERAO AJIT;;TODKAR MANGESH,,https://lens.org/082-825-625-051-90X,Patent Application,yes,3,0,1,1,0,C07K5/1024,C07D403/12;;C07D209/52,,1,0,,,"LIU, YONGGUI ET AL.: ""NS3/4A serine proteinase inhibitor-Telaprevir"", DRUG EVALUATION RESEARCH, vol. 34, no. 5, 31 October 2011 (2011-10-31), pages 392 - 397",PENDING
